Sensei Biotherapeutics, Inc.

SNSE · Nasdaq · SIC 2834: Pharmaceutical Preparations
105
SEC Filings

Business Summary

PART I Item 1. B usiness. In this Annual Report, unless the context otherwise dictates, the terms (i) we, us, our, Sensei, the Company and other similar terms refer to the business and operations of Sensei Biotherapeutics, Inc. and its consolidated subsidiaries for periods prior to the Acquisition (as defined below) and to Sensei Biotherapeutics, Inc. and its consolidated subsidiaries, including Faeth Therapeutics for periods after the Acquisition; (ii) Faeth HoldCo refers to Faeth Holdings Ther...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSNSEdiscussed_in_filing Cybersecurity
topic_mentionSNSEdiscussed_in_filing Cybersecurity
topic_mentionSNSEdiscussed_in_filing Blockchain & Crypto
topic_mentionSNSEdiscussed_in_filing Healthcare & Bio
topic_mentionSNSEdiscussed_in_filing Blockchain & Crypto
topic_mentionSNSEdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-132014EDGAR94K words
2025-03-282024-12-310000950170-25-046338EDGAR—
2024-02-292023-12-310000950170-24-023148EDGAR—
2023-03-292022-12-310000950170-23-010432EDGAR—
2022-03-152021-12-310000950170-22-003646EDGAR—
2021-03-302020-12-310001564590-21-016297EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001193125-25-281590EDGAR55K words
2025-08-052025-06-300000950170-25-103101EDGAR—
2025-05-062025-03-310000950170-25-064525EDGAR—
2024-11-142024-09-300000950170-24-126748EDGAR—
2024-08-062024-06-300000950170-24-091895EDGAR—
2024-05-092024-03-310000950170-24-057106EDGAR—
2023-11-072023-09-300000950170-23-060340EDGAR—
2023-08-032023-06-300000950170-23-038085EDGAR—
2023-05-092023-03-310000950170-23-019754EDGAR—
2022-11-082022-09-300000950170-22-023276EDGAR—
2022-08-092022-06-300000950170-22-016148EDGAR—
2022-05-102022-03-310000950170-22-009054EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-130419EDGAR1K words
2026-02-180001193125-26-056135EDGAR—
2026-02-130001193125-26-051815EDGAR—
2025-12-230001193125-25-331113EDGAR—
2025-11-140001193125-25-281581EDGAR—
2025-10-300001193125-25-257621EDGAR—
2025-10-170001193125-25-242007EDGAR—
2025-08-050001193125-25-173043EDGAR—
2025-07-090001193125-25-157113EDGAR—
2025-06-130001193125-25-140329EDGAR—

105 total filings indexed. 77 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001829802
TickerSNSE
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c66c7c76569a25f8ded3b336aa323039228975bd1dd6b7767ffeec3d56485cc2
parent: 45708d8035ebb6310116ece51911bad579eebc0be17f4992f93361df494d1794
content hash: 0a12424b122608564fb99ba74e2e64afdf2df9bcfdfca0c24c2ef4035c1d4a60
signed: 2026-04-13T04:47:31.865Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf